Ladan Golestaneh

Ladan Golestaneh

Auto-generated profile, based on publicly available information

Ladan Golestaneh

Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
MFMolly Fisher
Molly Fisher
JNJoel Neugarten
Joel Neugarten
EBEran Bellin
Eran Bellin
MYMilagros Yunes
Milagros Yunes
LSLindsay Stahl
Lindsay Stahl
LGLadan Golestaneh
Ladan Golestaneh
Significance Statement: Centers have reported a wide range of AKI incidence rates among patients hospitalized with coronavirus disease 2019 (COVID-19). In a retrospective observational study, the authors compared the incidence, risk factors, and outcomes of AKI in hospitalized adults with and without COVID-19 in a large New York City health system. Compared with patients without COVID-19 and with historical controls, patients with COVID-19 had a significantly higher incidence of AKI; were more likely to require RRT, intensive care unit admission, and mechanical ventilation; and were more likely to experience in-hospital death. Male sex, Black race, and older age were associated with AKI, but these associations were not unique to COVID-19. Select initial vital signs at hospital admission and inflammatory markers were predictors of severe AKI. Background: Reports from centers treating patients with coronavirus disease 2019 (COVID-19) have noted that such patients frequently develop AKI. However, there have been no direct comparisons of AKI in hospitalized patients with and without COVID-19 that would reveal whether there are aspects of AKI risk, course, and outcomes unique to this infection. Methods: In a retrospective observational study, we evaluated AKI incidence, risk factors, and outcomes for 3345 adults with COVID-19 and 1265 without COVID-19 who were hospitalized in a large New York City health system and compared them with a historical cohort of 9859 individuals hospitalized a year earlier in the same health system. We also developed a model to identify predictors of stage 2 or 3 AKI in our COVID-19. Results: We found higher AKI incidence among patients with COVID-19 compared with the historical cohort (56.9% versus 25.1%, respectively). Patients with AKI and COVID-19 were more likely than those without COVID-19 to require RRT and were less likely to recover kidney function. Development of AKI was significantly associated with male sex, Black race, and older age (>50 years). Male sex and age >50 years associated with the composite outcome of RRT or mortality, regardless of COVID-19 status. Factors that were predictive of stage 2 or 3 AKI included initial respiratory rate, white blood cell count, neutrophil/lymphocyte ratio, and lactate dehydrogenase level. Conclusions: Patients hospitalized with COVID-19 had a higher incidence of severe AKI compared with controls. Vital signs at admission and laboratory data may be useful for risk stratification to predict severe AKI. Although male sex, Black race, and older age associated with development of AKI, these associations were not unique to COVID-19.

1 August 2020 in eClinicalMedicine
Verified
Journal Article
Open access
LGLadan Golestaneh
Ladan Golestaneh
JNJoel Neugarten
Joel Neugarten
MFMolly Fisher
Molly Fisher
HBHenny H. Billett
Henny H. Billett
MGMorayma Reyes Gil
Morayma Reyes Gil
EBEran Bellin
Eran Bellin
COVID-19 mortality disproportionately affects the Black population in the United States (US). To explore this association a cohort study was undertaken. We assembled a cohort of 505,992 patients receiving ambulatory care at Bronx Montefiore Health System (BMHS) between 1/1/18 and 1/1/20 to evaluate the relative risk of hospitalization and death in two time-periods, the pre-COVID time-period (1/1/20–2/15/20) and COVID time-period (3/1/20–4/15/20). COVID testing, hospitalization and mortality were determined with the Black and Hispanic patient population compared separately to the White population using logistic modeling. Evaluation of the interaction of pre-COVID and COVID time periods and race, with respect to mortality was completed. A total of 9,286/505,992 (1.8%) patients were hospitalized during either or both pre-COVID or COVID periods. Compared to Whites the relative risk of hospitalization of Black patients did not increase in the COVID period (p for interaction=0.12). In the pre- COVID period, compared to Whites, the odds of death for Blacks and Hispanics adjusted for comorbidity was statistically equivalent. In the COVID period compared to Whites the adjusted odds of death for Blacks was 1.6 (95% CI 1.2–2.0, p = 0.001). There was a significant increase in Black mortality risk from pre-COVID to COVID periods (p for interaction=0.02). Adjustment for relevant clinical and social indices attenuated but did not fully explain the observed difference in Black mortality. The BMHS COVID experience demonstrates that Blacks do have a higher mortality with COVID incompletely explained by age, multiple reported comorbidities and available metrics of sociodemographic disparity. N/A

8 November 2018 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
JNJoel Neugarten
Joel Neugarten
LGLadan Golestaneh
Ladan Golestaneh
Female sex has been included as a risk factor in models developed to predict the development of AKI. In addition, the commentary to the Kidney Disease Improving Global Outcomes Clinical Practice Guideline for AKI concludes that female sex is a risk factor for hospital-acquired AKI. In contrast, a protective effect of female sex has been demonstrated in animal models of ischemic AKI. To further explore this issue, we performed a meta-analysis of AKI studies published between January, 1978 and April, 2018 and identified 83 studies reporting sex-stratified data on the incidence of hospital-associated AKI among nearly 240,000,000 patients. Twenty-eight studies (6,758,124 patients) utilized multivariate analysis to assess risk factors for hospital-associated AKI and provided sex-stratified ORs. Meta-analysis of this cohort showed that the risk of developing hospital-associated AKI was significantly greater in men than in women (OR 1.23 (1.11,1.36). Since AKI is not a single disease but instead represents a heterogeneous group of disorders characterized by an acute reduction in renal function, we performed subgroup meta-analyses. The association of male sex with AKI was strongest among studies of patients who underwent non-cardiac surgery. Male sex was also associated with AKI in studies which included unselected hospitalized patients and in studies of critically ill patients who received care in an intensive care unit. In contrast, cardiac surgery-associated AKI and radiocontrast-induced AKI showed no sexual dimorphism. Our meta-analysis contradicts the established belief that female sex confers a greater risk of AKI and instead suggests a protective role.

8 June 2018 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
JNJoel Neugarten
Joel Neugarten
LGLadan Golestaneh
Ladan Golestaneh
NKNitin V. Kolhe
Nitin V. Kolhe
Female sex has been included as a risk factor in models developed to predict the risk of acute kidney injury (AKI) associated with cardiac surgery, aminoglycoside nephrotoxicity and contrast-induced nephropathy. The commentary acompanying the Kidney Disease Improving Global Outcomes Clinical Practice Guideline for Acute Kidney Injury concludes that female sex is a shared susceptibility factor for acute kidney injury based on observations that female sex is associated with the development of hospital-acquired acute kidney injury. In contrast, female sex is reno-protective in animal models. In this context, we sought to examine the role of sex in hospital-associated acute kidney injury in greater detail. We utilized the Hospital Episode Statistics database to calculate the sex-stratified incidence of AKI requiring renal replacement therapy (AKI-D) among 194,157,726 hospital discharges reported for the years 1998–2013. In addition, we conducted a systematic review of the English literature to evaluate dialysis practices among men versus women with AKI. Hospitalized men were more likely to develop AKI-D than hospitalized women (OR 2.19 (2.15, 2.22) p < 0.0001). We found no evidence in the published literature that dialysis practices differ between men and women with AKI. Based on a population of hospitalized patients which is more than 3 times larger than all previously published cohorts reporting sex-stratified AKI data combined, we conclude that male sex is associated with an increased incidence of hospital-associated AKI-D. Our study is among the first reports to highlight the protective role of female gender in AKI.

5 December 2019 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
MFMolly Fisher
Molly Fisher
LGLadan Golestaneh
Ladan Golestaneh
MAMichael Allon
Michael Allon
KAKenneth Abreo
Kenneth Abreo
MMMichele H. Mokrzycki
Michele H. Mokrzycki
Bloodstream infections are an important cause of hospitalizations, morbidity, and mortality in patients receiving hemodialysis. Eliminating bloodstream infections in the hemodialysis setting has been the focus of the Centers for Disease Control and Prevention (CDC) Making Dialysis Safer for Patients Coalition and, more recently, the CDC’s partnership with the American Society of Nephrology’s Nephrologists Transforming Dialysis Safety Initiative. The majority of vascular access–associated bloodstream infections occur in patients dialyzing with central vein catheters. The CDC’s core interventions for bloodstream infection prevention are the gold standard for catheter care in the hemodialysis setting and have been proven to be effective in reducing catheter-associated bloodstream infection. However, in the United States hemodialysis catheter–associated bloodstream infections continue to occur at unacceptable rates, possibly because of lapses in adherence to strict aseptic technique, or additional factors not addressed by the CDC’s core interventions. There is a clear need for novel prophylactic therapies. This review highlights the recent advances and includes a discussion about the potential limitations and adverse effects associated with each option.

1 June 2017
Verified
Journal Article
Closed access
LGLadan Golestaneh
Ladan Golestaneh
PAPaula J. Alvarez
Paula J. Alvarez
NRNancy L. Reaven
Nancy L. Reaven
SFSusan E. Funk
Susan E. Funk
KMKaren J. McGaughey
Karen J. McGaughey
MOMacaulay Onuigbo
Macaulay Onuigbo